The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Open accessAbstract
Obesity is a public health problem that has reached epidemic proportions with an increasing worldwide prevalence. The global emergence of obesity increases the risk of developing chronic metabolic disorders. Thus, it is an economic issue that increased the costs of the comorbidities associated. Moreover, in recent years, it has been demonstrated that obesity is associated with chronic systemic inflammation, this status is conditioned by the innate immune system activation in adipose tissue that promotes an increase in the production and release of pro-inflammatory cytokines that contribute to the triggering of the systemic acute-phase response which is characterized by elevation of acute-phase protein levels. On this regard, low-grade chronic inflammation is a characteristic of various chronic diseases such as metabolic syndrome, cardiovascular disease, diabetes, hypertension, non-alcoholic fatty liver disease, and some cancers, among others, which are also characterized by obesity condition. Thus, a growing body of evidence supports the important role that is played by the inflammatory response in obesity condition and the pathogenesis of chronic diseases related.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Many studies also implicate chronic low grade inflammation in the interplay between obesity and metabolic complications, as many chronic degenerative disorders, including atherosclerosis, and are also commonly associated with hypertension, which itself has also been linked recently to inflammation [8, 9].”
BackgroundAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Though in mild degree, chronic elevation of CRP levels, even within normal value range, is an independent predictor of future cardiovascular events [99, 104].”
BackgroundInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
(1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.899 · Cited by 2,700
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · cited 1×
“[101] P.”
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,362
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292 · cited 2×
“Moreover, several studies have shown that statin therapy is associated with reduced inflammation and cardiovascular risk reduction [108, 129–141].”
BackgroundRidker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Troiano, R. P. (1995) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1995.02170230039005 · Cited by 1,427
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 4×
“Interestingly, circulating TNF-alpha levels are higher in type 2 diabetes [161–163] as compared with IFG/IGT [156].”
BackgroundInfluentialRidker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Steel, D. M., & Whitehead, A. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90138-4 · Cited by 1,025
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010
Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study
Cesari, M., Penninx, B. W. J. H., Newman, A. B., Kritchevsky, S. B., Nicklas, B. J., Sutton-Tyrrell, K., Rubin, S. M., Ding, J., Simonsick, E. M., Harris, T. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000097109.90783.fc · Cited by 978
Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction
Rosenson, R. S., & Tangney, C. C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Adipokines: molecular links between obesity and atheroslcerosis
Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 931
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
Castell, J. V., Gómez-Lechón, M. J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R., & Heinrich, P. C. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80476-4 · Cited by 893
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
The Obesity Epidemic: Pathophysiology and Consequences of Obesity
Pi‐Sunyer, F. X. (2002) · Obesity Research · doi:10.1038/oby.2002.202 · Cited by 858
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue
Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055188.83694.b3 · Cited by 851
Farrell, P. M., Kosorok, M. R., Rock, M. J., Laxova, A., Zeng, L., Lai, H.-C., Hoffman, G., Laessig, R. H., Splaingard, M. L., & the Wisconsin Cystic Fibrosis Neonatal Screening Study Group (2001) · Pediatrics · doi:10.1542/peds.107.1.1 · Cited by 837
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
C-Reactive Protein as a Cardiovascular Risk Factor: More Than an Epiphenomenon?
Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G.-J., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833
McKeown, N. M., Meigs, J. B., Liu, S., Saltzman, E., Wilson, P. W. F., & Jacques, P. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.538 · Cited by 786
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · cited 1×
“It contributes to chronic inflammation in conditions such as obesity, insulin resistance, inflammatory bowel disease, inflammatory arthritis, and sepsis when deregulated [39].”
BackgroundFreeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Inflammatory pathways and insulin action
Hotamisligil, G. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802502 · Cited by 717
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Overweight prevalence and trends for children and adolescents
RP, T., KM, F., & RJ, K. (1996) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199604000-00035 · Cited by 710
Singh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 1×
“Some interventional studies using Mediterranean diet and others characterized by increased intake of mustard or soybean oil, fruits, vegetables, nuts, and whole grains reduced the rate of cardiovascular disease with significant anti-inflammatory effect [120, 121].”
BackgroundMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14955 · Cited by 621
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
Phosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598 · cited 1×
“The increase in cytokines exacerbates receptor activation by establishing a positive feedback loop of inflammation and the inhibitory signaling of metabolic pathways [26].”
BackgroundPlasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566
Vozarova, B., Weyer, C., Lindsay, R. S., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.455 · Cited by 564
Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., Willett, W. C., & Rimm, E. B. (2003) · Circulation · doi:10.1161/01.cir.0000079224.46084.c2 · Cited by 560
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 545
Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000017493.03108.1c · Cited by 533
Zhao, G., Etherton, T. D., Martin, K. R., West, S. G., Gillies, P. J., & Kris-Etherton, P. M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.2991 · Cited by 526
Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 513
Maeda, K., Cao, H., Kono, K., Gorgun, C. Z., Furuhashi, M., Uysal, K. T., Cao, Q., Atsumi, G., Malone, H., Krishnan, B., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.008 · Cited by 477
Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance
Shoelson, S. E., Lee, J., & Yuan, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802501 · Cited by 474
Trends and Correlates of Class 3 Obesity in the United States From 1990 Through 2000
Freedman, D. S. (2002) · JAMA · doi:10.1001/jama.288.14.1758 · Cited by 458
Castell, J. V., Gómez-Lechón, M. J., David, M., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80766-x · Cited by 452
C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000093381.57779.67 · Cited by 448
Sex hormones, inflammation and the metabolic syndrome: a population-based study
Laaksonen, D., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T., Salonen, R., Rauramaa, R., & Salonen, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490601 · Cited by 438
Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427 · cited 1×
“Similarly, weight reduction observed in subjects after gastric bypass shows decrease of CRP and IL-6 levels [60].”
BackgroundSakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease
Caballero, A. E. (2003) · Obesity Research · doi:10.1038/oby.2003.174 · Cited by 416
Low-Grade Systemic Inflammation in Overweight Children
Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., & Harris, T. B. (2001) · Pediatrics · doi:10.1542/peds.107.1.e13 · Cited by 402
Myers, G. L., Rifai, N., Tracy, R. P., Roberts, W. L., Alexander, R. W., Biasucci, L. M., Catravas, J. D., Cole, T. G., Cooper, G. R., Khan, B. V., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148980.87579.5e · Cited by 391
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., Shoelson, S. E., & for the TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00004 · Cited by 388
Lopez-Garcia, E., Schulze, M. B., Manson, J. E., Meigs, J. B., Albert, C. M., Rifai, N., Willett, W. C., & Hu, F. B. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.7.1806 · Cited by 380
Role of Cytokines in Inducing Hyperlipidemia
Feingold, K. R., & Grunfeld, C. (1992) · Diabetes · doi:10.2337/diab.41.2.s97 · Cited by 378
Inflammatory Markers and the Metabolic Syndrome
Koh, K. K., Han, S. H., & Quon, M. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.082 · Cited by 368
Thorand, B., Löwel, H., Schneider, A., Kolb, H., Meisinger, C., Fröhlich, M., & Koenig, W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.93 · Cited by 368
Mendall, M. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 357
Inflammation as a Link between Obesity and Metabolic Syndrome
Emanuela, F., Grazia, M., Marco, D. R., Maria Paola, L., Giorgio, F., & Marco, B. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/476380 · Cited by 357
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Fleischman, A., Shoelson, S. E., Bernier, R., & Goldfine, A. B. (2008) · Diabetes Care · doi:10.2337/dc07-1338 · Cited by 352
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Kuper, H., Tzonou, A., Kaklamani, E., Hsieh, C.-C., Lagiou, P., Adami, H.-O., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<498::aid-ijc9>3.0.co;2-f · Cited by 350
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide
Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D., Matsuoka, T.-A., Matsuhisa, M., Kajimoto, Y., Ichijo, H., Yamasaki, Y., & Hori, M. (2004) · Nature Medicine · doi:10.1038/nm1111 · Cited by 337
Heilbronn, L. K., Noakes, M., & Clifton, P. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.968 · Cited by 331
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322
Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.106.628909 · Cited by 313
Adipose tissue, insulin action and vascular disease: inflammatory signals
Yudkin, J. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802496 · Cited by 311 · cited 2×
“[44] J.”
BackgroundMüller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Primer: inflammasomes and interleukin 1β in inflammatory disorders
Church, L. D., Cook, G. P., & McDermott, M. F. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0681 · Cited by 309
Calabro, P., Chang, D. W., Willerson, J. T., & Yeh, E. T. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.017 · Cited by 308
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ
Kim, F., Tysseling, K. A., Rice, J., Pham, M., Haji, L., Gallis, B. M., Baas, A. S., Paramsothy, P., Giachelli, C. M., Corson, M. A., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160549.60980.a8 · Cited by 307
Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4618 · Cited by 301
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299 · cited 1×
“Thus, supported by a large number of observational studies and meta-analyses, CRP is considered as a mediator of cardiovascular disease [116], independently of age, smoking, cholesterol levels, blood pressure, and diabetes among others traditional risk factors evaluated in the clinical setting [117].”
BackgroundUse of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Goldfine, A. B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J., & Shoelson, S. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00026.x · Cited by 294
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Laaksonen, D. E., Niskanen, L., Nyyss�nen, K., Punnonen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetologia · doi:10.1007/s00125-004-1472-x · Cited by 289
Rallidis, L. S., Paschos, G., Liakos, G. K., Velissaridou, A. H., Anastasiadis, G., & Zampelas, A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00427-6 · Cited by 288
TNF-α and insulin resistance: Summary and future prospects
Peraldi, P., & Spiegelman, B. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865715292 · Cited by 286
Dietary patterns, inflammation and the metabolic syndrome
Ahluwalia, N., Andreeva, V. A., Kesse-Guyot, E., & Hercberg, S. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.08.007 · Cited by 272
The Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, J., Tousoulis, D., Toutouza, M., Toutouzas, P., & Stefanadis, C. (2004) · American Heart Journal · doi:10.1016/s0002-8703(03)00442-3 · Cited by 258
Williams, D. E. M., Prevost, A. T., Whichelow, M. J., Cox, B. D., Day, N. E., & Wareham, N. J. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500000337 · Cited by 250
Epidemiology of Obesity in the Western Hemisphere
Ford, E. S., & Mokdad, A. H. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1356 · Cited by 248
Djoussé, L., Pankow, J. S., Eckfeldt, J. H., Folsom, A. R., Hopkins, P. N., Province, M. A., Hong, Y., & Ellison, R. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.612 · Cited by 232
C-reactive protein is a mediator of cardiovascular disease
Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 232
Trichopoulos, D., Bamia, C., Lagiou, P., Fedirko, V., Trepo, E., Jenab, M., Pischon, T., Nothlings, U., Overved, K., Tjonneland, A., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr395 · Cited by 228
BMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
Orpana, H. M., Berthelot, J., Kaplan, M. S., Feeny, D. H., McFarland, B., & Ross, N. A. (2010) · Obesity · doi:10.1038/oby.2009.191 · Cited by 223
Influence of Metabolic Syndrome on Biomarkers of Oxidative Stress and Inflammation in Obese Adults
Van Guilder, G. P., Hoetzer, G. L., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2006) · Obesity · doi:10.1038/oby.2006.248 · Cited by 216
Kuller, L. H., Eichner, J. E., Orchard, T. J., Grandits, G. A., McCallum, L., Tracy, R. P., & for the Multiple Risk Factor Intervention Trial Research Group (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116030 · Cited by 199
Herbert Haught, W., Mansour, M., Rothlein, R., Kishimoto, T. K., Mainolfi, E. A., Hendricks, J. B., Hendricks, C., & Mehta, J. L. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90383-x · Cited by 190
Anty, R., Bekri, S., Luciani, N., Saint-Paul, M.-C., Dahman, M., Iannelli, A., Amor, I. B., Staccini-Myx, A., Huet, P.-M., Gugenheim, J., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00724.x · Cited by 189
Hak, A. E., Pols, H. A. P., Stehouwer, C. D. A., Meijer, J., Kiliaan, A. J., Hofman, A., Breteler, M. M. B., & Witteman, J. C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7873 · Cited by 184
Roberts, W. L. (2004) · Circulation · doi:10.1161/01.cir.0000148986.52696.07 · Cited by 178
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia
Musial, J., Undas, A., Gajewski, P., Jankowski, M., Sydor, W., & Szczeklik, A. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00439-3 · Cited by 176
Risk Factor Clustering in the Insulin Resistance Syndrome: The Strong Heart Study
Gray, R. S., Fabsitz, R. R., Cowan, L. D., Lee, E. T., Howard, B. V., & Savage, P. J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009712 · Cited by 166
Wæhre, T., Yndestad, A., Smith, C., Haug, T., Tunheim, S. H., Gullestad, L., Frøland, S. S., Semb, A. G., Aukrust, P., & Damås, J. K. (2004) · Circulation · doi:10.1161/01.cir.0000125700.33637.b1 · Cited by 165
Wang, B., & Trayhurn, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0055-8 · Cited by 163
C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo
Bataille, R., & Klein, B. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350824 · Cited by 162
Nakanishi, S., Yamane, K., Kamei, N., Okubo, M., & Kohno, N. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2754 · Cited by 161
Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., Olmos, M. Á. M., & Vidal, O. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602384 · Cited by 159
Temelkova-Kurktschiev, T. S., Siegert, G., Bergmann, S., Henkel, E., Koehler, C., Jaroszlig, W., & Markolf Hanefeld, E. (2002) · Metabolism · doi:10.1053/meta.2002.32804 · Cited by 155
C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease
Madsen, T., Skou, H. A., Hansen, V. E., Fog, L., Christensen, J. H., Toft, E. S., & Schmidt, E. B. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02049-5 · Cited by 151
Steinberg, G. R. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4135 · Cited by 150
Kaplan, M. S., Huguet, N., Newsom, J. T., McFarland, B. H., & Lindsay, J. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.11.m1018 · Cited by 148
Katsuki, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.859 · Cited by 129
Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601938 · Cited by 123
Koška, J., Ortega, E., Bunt, J. C., Gasser, A., Impson, J., Hanson, R. L., Forbes, J. M., de Courten, B. V., & Krakoff, J. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1239-x · Cited by 122
Stenlöf, K., Wernstedt, I., Fjällman, T., Wallenius, V., Wallenius, K., & Jansson, J.-O. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021733 · Cited by 119
Jacobs, M., van Greevenbroek, M. M. J., Kallen, C., Ferreira, I., Blaak, E. E., Feskens, E. J. M., Jansen, E. H. J. M., Schalkwijk, C., & Stehouwer, C. D. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02129.x · Cited by 117
Kressel, G., Trunz, B., Bub, A., Hülsmann, O., Wolters, M., Lichtinghagen, R., Stichtenoth, D. O., & Hahn, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.012 · Cited by 113
Lapice, E., Maione, S., Patti, L., Cipriano, P., Rivellese, A. A., Riccardi, G., & Vaccaro, O. (2009) · Diabetes Care · doi:10.2337/dc09-0176 · Cited by 108
Wæhre, T., Damås, J. K., Gullestad, L. L., Holm, A. M., Pedersen, T. R., Arnesen, K. E., Torsvik, H., Frøland, S. S., Semb, A. G., & Aukrust, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00263-8 · Cited by 105
The inflammasome: in memory of Dr. Jurg Tschopp
Dagenais, M., Skeldon, A. M., & Saleh, M. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.159 · Cited by 104
Devaraj, S., Chan, E., & Jialal, I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0299 · Cited by 101
C-reactive protein is elevated in obese patients with the metabolic syndrome
Florez, H., Castillo-Florez, S., Mendez, A., Casanova-Romero, P., Larreal-Urdaneta, C., Lee, D., & Goldberg, R. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.05.003 · Cited by 97
Available, N. A. N. (2002) · Diabetologia · doi:10.1007/s125-002-8256-1 · Cited by 92
Inflammatory markers in relation to insulin resistance and the metabolic syndrome
Ingelsson, E., Hulthe, J., & Lind, L. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01962.x · Cited by 90
Tan, K. C. B., Wat, N. M. S., Tam, S., Janus, E. D., Lam, T., & Lam, K. S. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2323 · Cited by 87
C-Reactive Protein and 5-Year Survival in Type 2 Diabetes
Bruno, G., Fornengo, P., Novelli, G., Panero, F., Perotto, M., Segre, O., Zucco, C., Deambrogio, P., Bargero, G., & Perin, P. C. (2008) · Diabetes · doi:10.2337/db08-0900 · Cited by 77
Trunk Fat Is Associated With Increased Serum Levels of Alanine Aminotransferase in the United States
Ruhl, C. E., & Everhart, J. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.053 · Cited by 73
Fortmann, S. P., Ford, E. S., Criqui, M. H., Folsom, A. R., Harris, T. B., Hong, Y., Pearson, T. A., Siscovick, D. S., Vinicor, F., & Wilson, P. W. F. (2004) · Circulation · doi:10.1161/01.cir.0000148982.95775.bf · Cited by 69
Available, N. (1998) · Diabetologia · doi:10.1007/s001250051000 · Cited by 67
JNK: bridging the insulin signaling and inflammatory pathway.
Liu, G., & Rondinone, C. M. (2005) · PubMed · Cited by 59
Su, L. J., Mahabir, S., Ellison, G. L., McGuinn, L. A., & Reid, B. C. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2011.00091 · Cited by 55
Rodríguez-Hernández, H., Cervantes-Huerta, M., Morán, M. R., & Guerrero‐Romero, F. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31517-0 · Cited by 53
Self-citationEffect of a multidisciplinary program of weight reduction on endothelial functions in obese women
Nicoletti, G., Giugliano, G., Pontillo, A., Cioffi, M., D’Andrea, F., Giugliano, D., & Esposito, K. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345154 · Cited by 52
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214955 · Cited by 49
Rodríguez-Hernández, H., Morales-Amaya, U. A., Rosales-Valdéz, R., Rivera-Hinojosa, F., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991231 · Cited by 45
Self-citationStatin Use and the Risk of Incident Diabetes Mellitus: A Review of the Literature
Colbert, J. D., & Stone, J. A. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.021 · Cited by 39
Matsuo, Y., Hashizume, T., Shioji, S., & Akasaka, T. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0337 · Cited by 29
on behalf of the CanACTFAST Study Investigators, Rabkin, S. W., Langer, A., Ur, E., Calciu, C.-D., & Leiter, L. A. (2013) · Hypertension Research · doi:10.1038/hr.2012.214 · Cited by 28
Carantoni, M., Zuliani, G., Volpato, S., Palmieri, E., Mezzetti, A., Vergnani, L., & Fellin, R. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90236-0 · Cited by 21
Lazich, I., Sarafidis, P. A., Guzman, E., Patel, A. D., Oliva, R. R., & Bakris, G. L. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01510.x · Cited by 20
Wägner, A. M., Sánchez‐Quesada, J. L., Benı́tez, S., Bancells, C., Ordóñez‐Llanos, J., & Pérez, A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.03.009 · Cited by 19
C reactive protein and the risk of cardiovascular disease
Keavney, B. D. (2011) · BMJ · doi:10.1136/bmj.d144 · Cited by 18
Role of statin pleiotropism in acute coronary syndromes and stroke.
Liao, J. K. (2003) · PubMed · Cited by 17
(2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802346 · Cited by 4
Cited by
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Cardiovascular risk and obesity
Cercato, C., & Fonseca, F. A. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0468-0 · Cited by 395
Hodgson, K., Morris, J., Bridson, T., Govan, B., Rush, C., & Ketheesan, N. (2015) · Immunology · doi:10.1111/imm.12394 · Cited by 367
Alam, M. A., Subhan, N., Hossain, H., Hossain, M., Reza, H. M., Rahman, M. M., & Ullah, M. O. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0080-3 · Cited by 359
Kwaifa, I. K., Bahari, H., Yong, Y. K., & Noor, S. M. (2020) · Biomolecules · doi:10.3390/biom10020291 · Cited by 345
Metadata
- Authors
- Rodríguez-Hernández, H., Simental-Mendía, L. E., Rodríguez-Ramírez, G., & Reyes-Romero, M. A.
- Venue
- International Journal of Endocrinology
- Publisher
- Hindawi Limited
- Published
- 2013
- Volume
- 2013
- Pages
- 1-11
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2048048890
- Cited by
- 481
- References
- 188
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.